These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25638342)

  • 1. 2014 AHA/ACC Guideline for the Patients with Valvular Heart Disease.
    Zhang PY
    Cell Biochem Biophys; 2015 Jul; 72(3):829-31. PubMed ID: 25638342
    [No Abstract]   [Full Text] [Related]  

  • 2. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Nishimura RA; Otto CM; Bonow RO; Carabello BA; Erwin JP; Guyton RA; O'Gara PT; Ruiz CE; Skubas NJ; Sorajja P; Sundt TM; Thomas JD;
    Circulation; 2014 Jun; 129(23):2440-92. PubMed ID: 24589852
    [No Abstract]   [Full Text] [Related]  

  • 3. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
    Bonow RO; Carabello BA; Chatterjee K; de Leon AC; Faxon DP; Freed MD; Gaasch WH; Lytle BW; Nishimura RA; O'Gara PT; O'Rourke RA; Otto CM; Shah PM; Shanewise JS; ;
    Circulation; 2008 Oct; 118(15):e523-661. PubMed ID: 18820172
    [No Abstract]   [Full Text] [Related]  

  • 4. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Nishimura RA; Otto CM; Bonow RO; Carabello BA; Erwin JP; Guyton RA; O'Gara PT; Ruiz CE; Skubas NJ; Sorajja P; Sundt TM; Thomas JD;
    Circulation; 2014 Jun; 129(23):e521-643. PubMed ID: 24589853
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology Guidelines for the Management of Patients With Valvular Heart Disease.
    Alame AJ; Karatasakis A; Karacsonyi J; Danek BA; Sorajja P; Gössl M; Garcia S; Jneid H; Kakouros N; Martinez-Parachini JR; Resendes E; Kalsaria P; Roesle M; Rangan BV; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2017 Sep; 29(9):320-326. PubMed ID: 28420803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Nishimura RA; Otto CM; Bonow RO; Carabello BA; Erwin JP; Fleisher LA; Jneid H; Mack MJ; McLeod CJ; O'Gara PT; Rigolin VH; Sundt TM; Thompson A
    Circulation; 2017 Jun; 135(25):e1159-e1195. PubMed ID: 28298458
    [No Abstract]   [Full Text] [Related]  

  • 7. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Nishimura RA; Otto CM; Bonow RO; Carabello BA; Erwin JP; Fleisher LA; Jneid H; Mack MJ; McLeod CJ; O'Gara PT; Rigolin VH; Sundt TM; Thompson A
    J Am Coll Cardiol; 2017 Jul; 70(2):252-289. PubMed ID: 28315732
    [No Abstract]   [Full Text] [Related]  

  • 8. Perspective to 2020 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Management of Patients With Valvular Heart Disease.
    Bavry AA; Arnaoutakis GJ
    Circulation; 2021 Feb; 143(5):407-409. PubMed ID: 33332147
    [No Abstract]   [Full Text] [Related]  

  • 9. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Bonow RO; Nishimura RA; Thompson PD; Udelson JE
    J Am Coll Cardiol; 2015 Dec; 66(21):2385-2392. PubMed ID: 26542667
    [No Abstract]   [Full Text] [Related]  

  • 10. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Otto CM; Nishimura RA; Bonow RO; Carabello BA; Erwin JP; Gentile F; Jneid H; Krieger EV; Mack M; McLeod C; O'Gara PT; Rigolin VH; Sundt TM; Thompson A; Toly C
    Circulation; 2021 Feb; 143(5):e72-e227. PubMed ID: 33332150
    [No Abstract]   [Full Text] [Related]  

  • 11. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Nishimura RA; Otto CM; Bonow RO; Carabello BA; Erwin JP; Guyton RA; O'Gara PT; Ruiz CE; Skubas NJ; Sorajja P; Sundt TM; Thomas JD;
    J Am Coll Cardiol; 2014 Jun; 63(22):e57-185. PubMed ID: 24603191
    [No Abstract]   [Full Text] [Related]  

  • 12. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.
    Levine GN; Bates ER; Bittl JA; Brindis RG; Fihn SD; Fleisher LA; Granger CB; Lange RA; Mack MJ; Mauri L; Mehran R; Mukherjee D; Newby LK; O'Gara PT; Sabatine MS; Smith PK; Smith SC
    Circulation; 2016 Sep; 134(10):e123-55. PubMed ID: 27026020
    [No Abstract]   [Full Text] [Related]  

  • 13. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Nishimura RA; Otto CM; Bonow RO; Carabello BA; Erwin JP; Guyton RA; O'Gara PT; Ruiz CE; Skubas NJ; Sorajja P; Sundt TM; Thomas JD;
    J Am Coll Cardiol; 2014 Jun; 63(22):2438-88. PubMed ID: 24603192
    [No Abstract]   [Full Text] [Related]  

  • 14. The 2020 ACC/AHA Guidelines for Management of Patients With Valvular Heart Disease: Highlights and Perioperative Implications.
    Mohananey D; Aljadah M; Smith AAH; Haines JF; Patel S; Villablanca P; Ramakrishna H
    J Cardiothorac Vasc Anesth; 2022 May; 36(5):1467-1476. PubMed ID: 34011447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Bonow RO; Nishimura RA; Thompson PD; Udelson JE;
    Circulation; 2015 Dec; 132(22):e292-7. PubMed ID: 26621646
    [No Abstract]   [Full Text] [Related]  

  • 16. Operationalizing the 2014 ACC/AHA Guidelines for Valvular Heart Disease: A Guide for Clinicians.
    Nishimura RA; Carabello B
    J Am Coll Cardiol; 2016 May; 67(19):2289-2294. PubMed ID: 27173039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison.
    Coisne A; Lancellotti P; Habib G; Garbi M; Dahl JS; Barbanti M; Vannan MA; Vassiliou VS; Dudek D; Chioncel O; Waltenberger JL; Johnson VL; De Paulis R; Citro R; Pibarot P;
    J Am Coll Cardiol; 2023 Aug; 82(8):721-734. PubMed ID: 37587584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New strategies in the management of valvular heart disease : A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease.
    Lamm G
    Wien Klin Wochenschr; 2021 Aug; 133(15-16):786-789. PubMed ID: 34057577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new ESC/EACTS guidelines on the management of valvular heart disease.
    Vahanian A; Iung B
    Arch Cardiovasc Dis; 2012 Oct; 105(10):465-7. PubMed ID: 23062477
    [No Abstract]   [Full Text] [Related]  

  • 20. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
    Nishimura RA; Carabello BA; Faxon DP; Freed MD; Lytle BW; O'Gara PT; O'Rourke RA; Shah PM; Bonow RO; Carabello BA; Chatterjee K; de Leon AC; Faxon DP; Freed MD; Gaasch WH; Lytle BW; Nishimura RA; O'Gara PT; O'Rourke RA; Otto CM; Shah PM; Shanewise JS; Smith SC; Jacobs AK; Buller CE; Creager MA; Ettinger SM; Krumholz HM; Kushner FG; Lytle BW; Nishimura RA; Page RL; Tarkington LG; Yancy CW;
    Circulation; 2008 Aug; 118(8):887-96. PubMed ID: 18663090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.